Epigenetics and Epigenomics in Health and Disease 17-19 November 2022 Brussels
This International Meeting on “Epigenetics and Epigenomics in Health and Disease” integrated different sessions on: transcription and chromatin in gene regulation, DNA modifications, RNA epigenetics, non-coding RNA, epigenomic tools. Besides bringing the newest findings on epigenetic mechanisms, a special focus was also dedicated to discuss novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations.
The meeting gathered scientists using diverse approaches, such as molecular biology, cell biology genetics, epigenomics, and biochemistry. Researchers from pharmaceutical companies and clinicians working in different fields but sharing the same interests also found the meeting an ideal opportunity to meet, discuss and summarise their work.
Furthermore, to ensure that the conference touched upon the most recent breakthroughs in the fast moving field of epigenetics, there were slots for short talks based on submitted abstracts.
Overall, the meeting provided great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the booming area of epigenetics and epigenomics and their clinical impacts.
For details on EEHD 2024 please contact:
Liz Olsen
liz@precisionmedicineforum.com
Agenda (PDF)
Open the agenda for EEHD 2022 as a PDF in a separate tab.
Returning in 2024
#eehd22 Share the news
Over 220 Participants from 27 Countries
24 Invited speakers
5 short talk speakers
EEHD 2022 Speakers
Luciano Di Croce PhD
Dr. Di Croce’s laboratory addresses the molecular basis of epigenetic alterations during the early phase of tumorigenesis.
Dr. Yael David
Assistant Member at the Chemical Biology Program at Memorial Sloan Kettering Cancer Center
Rab Prinjha PhD
Adaptive Immunity and Immuno-Epigenetics Research Unit and cofounded the GSK Biology Council.
Cigall Kadoch, Ph.D.
Assistant Professor of Pediatric Oncology at the Dana-Farber Cancer Institute
Jean-Christophe Marine
Professor at KU Leuven (Belgium), senior VIB group leader and Director of the VIB center for Cancer Biology.
Prof Mark Dawson
Clinician-scientist at the Peter MacCallum Cancer Centre and Centre for Cancer Research University of Melbourne.
Karen Adelman
Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School.
Giacomo Cavalli
In 1999, he moved to IGH in Montpellier, France, to set up a junior lab and stayed at IGH ever since.
Andrea Schorn
Early 2019 she started her own independent lab at CSHL. The lab is interested in mechanisms of small RNA-mediated transposon control.
Chuan He, Ph.D.
John T. Wilson Distinguished Service Professor Dept. of Chemistry and Biochemistry and Molecular Biology at the University of Chicago.
Richard I. Gregory. Ph.D.
Professor and Stem Cell Biology Chair, in the Departments of Pediatrics, and Biological Chemistry and Molecular Pharmacology at Harvard Medical School.
Ramin Shiekhattar
A Director of Cancer Epigenetics Program, Chief of Division of Cancer Genomics & Epigenetics and Professor of Human Genetics.
Shelley Berger, Ph.D.
Daniel S. Och University Professor at University of Pennsylvania (Penn).
Prof. Kristian Helin
Kristian Helin, CEO of The Institute of Cancer Research, professor at the University of London, research fellow at Harvard Medical School
Johnathan Whetstine, PhD
Cancer Epigenetics Program Leader, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA
Danette Daniels Ph.D
Vice President of the Protein Degrader Platform at Foghorn Therapeutics
Alexander Tarakhovsky, M.D., Ph.D.
Professor and Head of the Laboratory for the Immune Cell Epigenetics and Signaling at The Rockefeller University.
Anne Schaefer MD, PhD
Tenured Professor at the Friedman Brain Institute at Icahn School of Medicine at Mount Sinai, New York
Dr. Michael G. Kharas
Member of the Molecular Pharmacology Program at the Memorial Sloan-Kettering Cancer Center
Rob Martienssen
Rob Martienssen is a Professor at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute.
Sponsorship Opportunities
Nordic Precision Medicine Forum offers a unique environment to make new connections, share ideas and formulate partnerships for future collaboration. We work closely with our sponsors to ensure that your objectives are met by building bespoke marketing solutions. So be it a plenary speaking slot, hosting a roundtable or exhibiting at our forum, we ensure you are in front of the right audience.